Literature DB >> 20503403

Human mammary tumor virus in inflammatory breast cancer.

Beatriz G-T Pogo1, James F Holland, Paul H Levine.   

Abstract

The authors have found that retroviral sequences with 85% to 95% homology to the mouse mammary tumor virus were present in 40% of the sporadic breast cancers of American women. These sequences were not found in normal breasts or other tumors. A whole proviral structure was detected in 2 tumors. Breast cancer cells in culture were shown to contain and shed betaretroviral particles. This virus was designated human mammary tumor virus (HMTV). The authors have investigated the presence of HMTV sequences in a variety of breast conditions and geographic locations. Here they report that inflammatory breast cancer from American women shows a higher incidence of viral sequences (71%) than sporadic breast cancers. Similar incidence has been found in inflammatory breast cancers from Tunisia, and in gestational breast cancers. Because these conditions represent highly invasive malignancies, it is concluded that HMTV is sometimes associated with a particularly malignant phenotype. Copyright 2010 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20503403     DOI: 10.1002/cncr.25179

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  20 in total

1.  Prophylactic cancer vaccination by targeting functional non-self.

Authors:  Vincent K Tuohy; Ritika Jaini
Journal:  Ann Med       Date:  2011-06-09       Impact factor: 4.709

Review 2.  Inflammatory breast cancer clusters: A hypothesis.

Authors:  Paul H Levine; Salman Hashmi; Ashley A Minaei; Carmela Veneroso
Journal:  World J Clin Oncol       Date:  2014-08-10

3.  Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients.

Authors:  Nabila Chaher; Hugo Arias-Pulido; Nadija Terki; Clifford Qualls; Kamel Bouzid; Claire Verschraegen; Anne Marie Wallace; Melanie Royce
Journal:  Breast Cancer Res Treat       Date:  2011-03-01       Impact factor: 4.872

4.  Detection and identification of mouse mammary tumor virus-like DNA sequences in blood and breast tissues of breast cancer patients.

Authors:  Wasifa Naushad; Talha Bin Rahat; Miriam Kathleen Gomez; Muhammad Taimoor Ashiq; Muhammad Younas; Hajra Sadia
Journal:  Tumour Biol       Date:  2014-05-19

Review 5.  New Treatment Strategies for the Inflammatory Breast Cancer.

Authors:  Elena Vagia; Massimo Cristofanilli
Journal:  Curr Treat Options Oncol       Date:  2021-04-24

6.  Detection of MMTV-Like sequences in Moroccan breast cancer cases.

Authors:  Meriem Slaoui; Mohammed El Mzibri; Rachid Razine; Zineb Qmichou; Mohammed Attaleb; Mariam Amrani
Journal:  Infect Agent Cancer       Date:  2014-11-10       Impact factor: 2.965

7.  Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells.

Authors:  Evan N Cohen; Hui Gao; Simone Anfossi; Michal Mego; Neelima G Reddy; Bisrat Debeb; Antonio Giordano; Sanda Tin; Qiong Wu; Raul J Garza; Massimo Cristofanilli; Sendurai A Mani; Denise A Croix; Naoto T Ueno; Wendy A Woodward; Raja Luthra; Savitri Krishnamurthy; James M Reuben
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

8.  In Vitro Assessment of the Inflammatory Breast Cancer Cell Line SUM 149: Discovery of 2 Single Nucleotide Polymorphisms in the RNase L Gene.

Authors:  Brandon T Nokes; Heather E Cunliffe; Bonnie Lafleur; David W Mount; Robert B Livingston; Bernard W Futscher; Julie E Lang
Journal:  J Cancer       Date:  2013-01-10       Impact factor: 4.207

9.  Identification of diverse full-length endogenous betaretroviruses in megabats and microbats.

Authors:  Joshua A Hayward; Mary Tachedjian; Jie Cui; Hume Field; Edward C Holmes; Lin-Fa Wang; Gilda Tachedjian
Journal:  Retrovirology       Date:  2013-03-27       Impact factor: 4.602

Review 10.  Role of viruses in the development of breast cancer.

Authors:  Kenneth Alibek; Ainur Kakpenova; Assel Mussabekova; Marzhan Sypabekova; Nargis Karatayeva
Journal:  Infect Agent Cancer       Date:  2013-09-02       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.